Personalized Psychiatry
A Global Strategic Business Report
MCP35507
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (55)
3
CXO5
VICE PRESIDENT10
DIRECTOR25
MANAGER12
MARKETINGHIGHLIGHTS & REPORT INDEX
Global Personalized Psychiatry Market to Reach US$7.5 Billion by 2030
The global market for Personalized Psychiatry estimated at US$4.4 Billion in the year 2024, is expected to reach US$7.5 Billion by 2030, growing at a CAGR of 9.3% over the analysis period 2024-2030. Products, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$4.3 Billion by the end of the analysis period. Growth in the Services segment is estimated at 10.2% CAGR over the analysis period.
The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 12.6% CAGR
The Personalized Psychiatry market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 12.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 8.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.
Global Personalized Psychiatry Market – Key Trends & Drivers Summarized
How Is the Shift Toward Precision Mental Health Transforming the Practice of Psychiatry?
Personalized psychiatry, also known as precision psychiatry, is redefining the landscape of mental health treatment by leveraging genetic, neurobiological, and environmental data to guide individualized care. Traditional psychiatric treatment has long struggled with variability in drug efficacy, trial-and-error prescriptions, and poorly understood diagnostic boundaries. Personalized psychiatry seeks to overcome these limitations through biomarker-based diagnosis, pharmacogenomic testing, and neuroimaging-guided treatment planning—offering the potential to match the right intervention to the right patient at the right time.
Growing evidence in neuroscience and genomics is enabling more targeted approaches to disorders such as depression, schizophrenia, bipolar disorder, and anxiety. Tools like polygenic risk scores, EEG-based pattern recognition, and machine learning models are increasingly being integrated into psychiatric evaluations. These advancements are improving diagnostic accuracy, reducing adverse drug reactions, and enhancing therapeutic outcomes—particularly in patients with treatment-resistant conditions or comorbidities.
Why Are Pharmacogenomics and Digital Phenotyping Reshaping Psychiatric Intervention Strategies?
Pharmacogenomics has become a cornerstone of personalized psychiatry, offering clinicians actionable insights into how individual genetic profiles influence responses to psychiatric medications. Commercially available gene panels now analyze variations in CYP450 enzymes, serotonin transporters, and other pharmacodynamic targets, guiding the selection and dosing of antidepressants, antipsychotics, and mood stabilizers. This approach minimizes side effects, speeds up therapeutic response, and reduces the burden of trial-based prescribing practices.
Simultaneously, digital phenotyping is gaining traction as a real-time, non-invasive tool for monitoring mood, cognition, and behavior through smartphone sensors, voice analysis, and wearable devices. These technologies generate continuous behavioral data that can detect early signs of relapse, measure treatment response, and support adaptive interventions. Integration of digital biomarkers into clinical workflows is enabling dynamic, data-driven psychiatry that moves beyond episodic consultations toward longitudinal, patient-specific care.
How Are Regulatory Bodies, Reimbursement Systems, and AI Tools Influencing Clinical Adoption?
Regulatory progress is catalyzing market maturity in personalized psychiatry. Agencies such as the FDA and EMA have begun approving pharmacogenomic-based drug labeling and companion diagnostics in psychiatric care. In the U.S., CMS has expanded coverage for select pharmacogenetic tests, while several private insurers are reimbursing validated gene panels in major depressive disorder. These policy developments are encouraging broader clinical uptake and investment in companion diagnostics and AI-powered decision support tools.
AI and machine learning are also facilitating more robust prediction models for mental health conditions, enabling early intervention and stratified risk profiling. These algorithms are being trained on multimodal datasets—including genomics, imaging, EHRs, and wearable outputs—to identify subtypes within traditional diagnostic categories. This nuanced understanding of psychiatric pathophysiology is guiding the development of targeted therapies and supporting the emergence of precision mental health platforms that integrate diagnostics, therapeutics, and patient monitoring in a closed-loop system.
What’s Driving the Global Growth of the Personalized Psychiatry Market?
The growth in the personalized psychiatry market is driven by several factors including the rising prevalence of mental health disorders, growing awareness of interindividual treatment variability, and the convergence of genomics, neuroimaging, and digital health technologies. A primary growth driver is the global shift toward value-based care and outcome-driven reimbursement, which favors precise and effective treatment strategies over broad-spectrum pharmacotherapy.
Expanding access to genomic testing, proliferation of digital health startups, and growing academic-industry collaborations are accelerating the commercialization of personalized psychiatric tools. Moreover, the societal cost of ineffective psychiatric care—reflected in lost productivity, relapse rates, and healthcare expenditures—is incentivizing stakeholders to adopt predictive, personalized treatment models. As research continues to validate biomarkers and refine classification systems, personalized psychiatry is poised to become a foundational component of next-generation mental health care.
SCOPE OF STUDY
The report analyzes the Personalized Psychiatry market by the following Segments, and Geographic Regions/Countries:
Segments:
Type (Products, Services, Software); Therapeutic Area (Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction, Other Therapeutic Areas).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..
SELECT PLAYERS
23andMe; AltheaDx, Inc.; Arcara Personalized Psychiatry; BrainsWay Ltd.; BrightQuest Treatment Centers; CBT Plus; Genomind; GreyBird Ventures; HMNC Holding GmbH; Karuna Therapeutics; Mindstrong; Myriad Genetics; Peak Mental Wellness; Pear Therapeutics; Spring Health; Starling Minds; Sunovion Pharmaceuticals Inc.; Tempus AI; WayForward; Woebot Health
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| World Market Trajectories |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Personalized Psychiatry – Global Key Competitors Percentage Market Share in 2025 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 43 Players Worldwide in 2025 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Rising Demand for Precision Mental Health Treatments Propels Growth in Personalized Psychiatry Approaches |
| Expansion of Pharmacogenomic Testing Throws the Spotlight on Gene-Drug Interaction Profiling for Psychiatric Care |
| OEM Innovation in AI-Based Behavioral Analysis and Mood Tracking Enhances Tailored Therapy Plans |
| Growth in Use of Wearables and Mobile Apps Supports Continuous Monitoring and Response Optimization |
| OEM Development of Digital Biomarkers and Predictive Analytics Strengthens Early Intervention Capabilities |
| Surging Interest in Psychedelic-Assisted Therapies Fuels Precision-Based Dosing and Patient Matching Strategies |
| OEM Collaboration With Psychiatric Institutions and Genetic Labs Accelerates Research Translation to Clinical Use |
| Increasing Focus on Treatment-Resistant Depression Spurs Demand for Personalized Drug Response Tools |
| OEM Emphasis on Integrated Patient Profiling Across Clinical, Behavioral, and Genomic Data Enhances Decision-Making |
| Expansion of Telepsychiatry and Remote Mental Health Services Supports Digital Personalization Platforms |
| OEM Investment in Longitudinal Mental Health Data Models Enables Predictive Risk Assessment |
| Growth in Direct-to-Consumer Mental Health Diagnostics Encourages Patient Empowerment in Care Decisions |
| OEM Participation in Mental Health AI Consortia Supports Standardization of Algorithms and Clinical Outcomes |
| Surging Need for Adverse Event Prediction in Polypharmacy Cases Drives Use of Predictive Psychiatry Tools |
| OEM Development of Personalized CBT Protocols and AI-Driven Therapy Matching Enhances Efficacy |
| Increasing Payer and Government Support for Value-Based Mental Health Reimbursement Models Fuels Adoption |
| OEM Advances in Voice Analysis, Sleep Monitoring, and Micro-Expression Recognition Expand Non-Invasive Biomarkers |
| Rising Awareness of Comorbid Conditions Strengthens Demand for Integrated Personalized Care Pathways |
| OEM Entry Into Workplace Mental Wellness and Employer-Sponsored Care Programs Supports Commercial Scalability |
| Global Mental Health Burden and Treatment Gaps Propel Investment in Data-Driven, Personalized Psychiatric Solutions |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Personalized Psychiatry Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030 |
| World Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Personalized Psychiatry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Anxiety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Anxiety by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Anxiety by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Bipolar Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Bipolar Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Bipolar Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Schizophrenia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Addiction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Addiction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Addiction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| JAPAN |
| Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| CHINA |
| Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| EUROPE |
| Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Personalized Psychiatry by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| FRANCE |
| Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| GERMANY |
| Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Spain Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Russia Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Personalized Psychiatry by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| AUSTRALIA |
| Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E) |
| Australia Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Australia Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| INDIA |
| Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E) |
| India Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| India Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| SOUTH KOREA |
| South Korea Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| South Korea Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| LATIN AMERICA |
| Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E) |
| Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Personalized Psychiatry by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| ARGENTINA |
| Argentina Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Argentina Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| BRAZIL |
| Brazil Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Brazil Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| MEXICO |
| Mexico Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Mexico Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| REST OF LATIN AMERICA |
| Rest of Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Rest of Latin America Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| MIDDLE EAST |
| Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E) |
| Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Personalized Psychiatry by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Personalized Psychiatry by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| IRAN |
| Iran Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Iran Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| ISRAEL |
| Israel Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Israel Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| SAUDI ARABIA |
| Saudi Arabia Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Saudi Arabia Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| UNITED ARAB EMIRATES |
| UAE Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| UAE Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| REST OF MIDDLE EAST |
| Rest of Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Rest of Middle East Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
| AFRICA |
| Personalized Psychiatry Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E) |
| Africa Recent Past, Current & Future Analysis for Personalized Psychiatry by Type - Products, Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Personalized Psychiatry by Type - Products, Services and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Personalized Psychiatry by Type - Percentage Breakdown of Value Sales for Products, Services and Software for the Years 2015, 2025 & 2030 |
| Africa Recent Past, Current & Future Analysis for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Personalized Psychiatry by Therapeutic Area - Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Personalized Psychiatry by Therapeutic Area - Percentage Breakdown of Value Sales for Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction and Other Therapeutic Areas for the Years 2015, 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]